Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018

Marius Mølsted Flege; Margit Kriegbaum; Henrik Jørgensen; Bent Lind; Lise Bathum; Christen Andersen; Anna Engell

doi:10.1080/02813432.2023.2198584

Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018

Marius Mølsted Flege^*, Margit Kriegbaum, Henrik Jørgensen, Bent Lind, Lise Bathum, Christen Andersen, Anna Engell

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

16 Downloads (Pure)

Abstract

To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia.

Originalsprog	Engelsk
Tidsskrift	Scandinavian Journal of Primary Health Care
Vol/bind	41
Udgave nummer	2
Antal sider	9
ISSN	0281-3432
DOI	https://doi.org/10.1080/02813432.2023.2198584
Status	Udgivet - 2023

Bibliografisk note

Publisher Copyright:
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Adgang til dokumentet

10.1080/02813432.2023.2198584Licens: CC BY-NC

FulltextForlagets udgivne version, 1,67 MBLicens: CC BY-NC

Citationsformater

Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018. / Flege, Marius Mølsted; Kriegbaum, Margit; Jørgensen, Henrik; Lind, Bent; Bathum, Lise; Andersen, Christen; Engell, Anna.

I: Scandinavian Journal of Primary Health Care, Bind 41, Nr. 2, 2023.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{4b48473a59e24f289867fac9ef698d80,

title = "Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018",

abstract = "Objective: To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia. Design: Epidemiological cohort study. Setting: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre. Subjects: Cholesterol blood test results ordered by general practitioners in Greater Copenhagen were retrieved from 2000-2018. Using the International Standard Classification of Education classification, the population was categorized by length of education in three groups (basic education; up to 10 years, intermediate education; 11-12 years, advanced education; 13 years or more). The database comprised 13,019,486 blood sample results from 653,903 patients. Main Outcome Measures: Frequency of lipid measurement, prevalence of statin treatment, age and comorbidity at treatment initiation, total cholesterol threshold for statin treatment initiation, and achievement of treatment goal. Results: The basic education group was measured more frequently (1.46% absolute percentage difference of total population measured [95% CI 0.86%–2.05%] in 2000 and 9.67% [95% CI 9.20%–10.15%] in 2018) over the period compared to the intermediate education group. The advanced education group was younger when receiving first statin prescription (1.87 years younger [95% CI 1.02–2.72] in 2000 and 1.06 years younger [95% CI 0.54–1.58 in 2018) compared to the intermediate education group. All education groups reached the treatment goals equally well when statin treatment was initiated. Conclusion: Higher education was associated with earlier statin prescription, although the higher educated group was monitored less frequently. There was no difference in reaching treatment goal between the three education groups. These findings suggest patients with higher education level achieve an earlier dyslipidemia prevention intervention with an equally satisfying result compared to lower education patients.Key Points Little is known about the role of social inequality as a possible barrier for managing hypercholesterolemia in general practice. Increasing education level was associated to less frequent measurement and less frequent statin treatment. Patients with higher education level were younger, and less comorbidity at first statin prescription. Education level had no effect on frequency of statin treatment-initiated patients reaching the treatment goal was found.",

keywords = "educational status, epidemiology, general practice, Hypercholesteremia, hypolipidemic agents, lipids",

author = "Flege, {Marius M{\o}lsted} and Margit Kriegbaum and Henrik J{\o}rgensen and Bent Lind and Lise Bathum and Christen Andersen and Anna Engell",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2023",

doi = "10.1080/02813432.2023.2198584",

language = "English",

volume = "41",

journal = "Scandinavian Journal of Primary Health Care",

issn = "0281-3432",

publisher = "Taylor & Francis",

number = "2",

}

TY - JOUR

T1 - Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018

AU - Flege, Marius Mølsted

AU - Kriegbaum, Margit

AU - Jørgensen, Henrik

AU - Lind, Bent

AU - Bathum, Lise

AU - Andersen, Christen

AU - Engell, Anna

PY - 2023

Y1 - 2023

N2 - Objective: To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia. Design: Epidemiological cohort study. Setting: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre. Subjects: Cholesterol blood test results ordered by general practitioners in Greater Copenhagen were retrieved from 2000-2018. Using the International Standard Classification of Education classification, the population was categorized by length of education in three groups (basic education; up to 10 years, intermediate education; 11-12 years, advanced education; 13 years or more). The database comprised 13,019,486 blood sample results from 653,903 patients. Main Outcome Measures: Frequency of lipid measurement, prevalence of statin treatment, age and comorbidity at treatment initiation, total cholesterol threshold for statin treatment initiation, and achievement of treatment goal. Results: The basic education group was measured more frequently (1.46% absolute percentage difference of total population measured [95% CI 0.86%–2.05%] in 2000 and 9.67% [95% CI 9.20%–10.15%] in 2018) over the period compared to the intermediate education group. The advanced education group was younger when receiving first statin prescription (1.87 years younger [95% CI 1.02–2.72] in 2000 and 1.06 years younger [95% CI 0.54–1.58 in 2018) compared to the intermediate education group. All education groups reached the treatment goals equally well when statin treatment was initiated. Conclusion: Higher education was associated with earlier statin prescription, although the higher educated group was monitored less frequently. There was no difference in reaching treatment goal between the three education groups. These findings suggest patients with higher education level achieve an earlier dyslipidemia prevention intervention with an equally satisfying result compared to lower education patients.Key Points Little is known about the role of social inequality as a possible barrier for managing hypercholesterolemia in general practice. Increasing education level was associated to less frequent measurement and less frequent statin treatment. Patients with higher education level were younger, and less comorbidity at first statin prescription. Education level had no effect on frequency of statin treatment-initiated patients reaching the treatment goal was found.

AB - Objective: To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia. Design: Epidemiological cohort study. Setting: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre. Subjects: Cholesterol blood test results ordered by general practitioners in Greater Copenhagen were retrieved from 2000-2018. Using the International Standard Classification of Education classification, the population was categorized by length of education in three groups (basic education; up to 10 years, intermediate education; 11-12 years, advanced education; 13 years or more). The database comprised 13,019,486 blood sample results from 653,903 patients. Main Outcome Measures: Frequency of lipid measurement, prevalence of statin treatment, age and comorbidity at treatment initiation, total cholesterol threshold for statin treatment initiation, and achievement of treatment goal. Results: The basic education group was measured more frequently (1.46% absolute percentage difference of total population measured [95% CI 0.86%–2.05%] in 2000 and 9.67% [95% CI 9.20%–10.15%] in 2018) over the period compared to the intermediate education group. The advanced education group was younger when receiving first statin prescription (1.87 years younger [95% CI 1.02–2.72] in 2000 and 1.06 years younger [95% CI 0.54–1.58 in 2018) compared to the intermediate education group. All education groups reached the treatment goals equally well when statin treatment was initiated. Conclusion: Higher education was associated with earlier statin prescription, although the higher educated group was monitored less frequently. There was no difference in reaching treatment goal between the three education groups. These findings suggest patients with higher education level achieve an earlier dyslipidemia prevention intervention with an equally satisfying result compared to lower education patients.Key Points Little is known about the role of social inequality as a possible barrier for managing hypercholesterolemia in general practice. Increasing education level was associated to less frequent measurement and less frequent statin treatment. Patients with higher education level were younger, and less comorbidity at first statin prescription. Education level had no effect on frequency of statin treatment-initiated patients reaching the treatment goal was found.

KW - educational status

KW - epidemiology

KW - general practice

KW - Hypercholesteremia

KW - hypolipidemic agents

KW - lipids

U2 - 10.1080/02813432.2023.2198584

DO - 10.1080/02813432.2023.2198584

M3 - Journal article

C2 - 37036064

AN - SCOPUS:85152414397

VL - 41

JO - Scandinavian Journal of Primary Health Care

JF - Scandinavian Journal of Primary Health Care

SN - 0281-3432

IS - 2

ER -